Discussing Rheumatology: Psa And Radiographic Progression

Discussing Rheumatology: PsA and Radiographic Progression

The Immune-Mediated Inflammatory Disease Forum

Discussing Rheumatology: PsA and Drug Retention

The Immune-Mediated Inflammatory Disease Forum

Low rates of radiographic progression with secukinumab treatment in PsA patients | Douglas Veale

Medicine Matters rheumatology

Expert Insights on PsA: How Do Personalized Treatment Options Transform Patient Outcomes?

Practice Point Communications

Talking PsA: Individualized Management Strategies in PSA: Diagnostic and Treatment Considerations

Practice Point Communications

Predicting Progression from Psoriasis to PsA: Dr. Robert Chao

1/12/18: Spondyloarthritis: Effective Strategies for Putting Out the Fire

UW Department of Medicine

ARCHES: radiographic progression in the absence of PSA progression in patients with mHSPC

Psoriatic Arthritis PsA vs Rheumatoid Arthritis RA | Rheumatologist Dr. Micah Yu

Five Advances in Spondyloarthritis

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

The Psoriatic March: PsA before PsO

Discussing Rheumatology: PsA & Hep B

The Immune-Mediated Inflammatory Disease Forum

Serum Biomarkers Distinguish Radiographic Progression in PsA: Dr. Robert Chao

FAQ: How do you interpret radiographic progression using modified-vdHS or mTSS

Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis

Dr. Julio Gonzalez on Radiographic Progression in Psoriatic Arthritis

EULAR 2022: Making the invisible visible in PsA and axSpA

EMJ

Medical Management of Spondyloarthritis Presented by Dr. Muhammad Asim Khan, MD, MACP, FRCP

SPONDYLITISdotORG

Mapping the Path to Better Patient Outcomes in Rheumatoid Arthritis and Psoriatic Arthritis